PA
CTGO icon

PharVision Advisers’s Contango Silver & Gold Inc CTGO Stock Holding History

PharVision Advisers’s Portfolio CTGO Stock Details CTGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,327
Closed -$208K – 744
2025
Q3 		$208K Buy
+8,327
New +$177K 0.12% 484

Other funds holding CTGO

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PharVision Advisers's CTGO Position: Q4 2025 in Review

PharVision Advisers sold out of Contango Silver & Gold Inc (CTGO) in Q4 2025, closing a stake of 8,327 shares — an estimated $208K sold.

PharVision Advisers first reported a position in CTGO in Q3 2025 and held it in 1 quarter. The position peaked at $208K in Q3 2025. 101 funds tracked by Wall St. Rank hold CTGO as of Q4 2025.

  • PharVision Advisers reported no remaining Contango Silver & Gold Inc position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 8,327 Contango Silver & Gold Inc shares in Q4 2025, an estimated $208K.
  • PharVision Advisers first reported a position in Contango Silver & Gold Inc in Q3 2025 and held it in 1 quarter.
  • PharVision Advisers's Contango Silver & Gold Inc position peaked at $208K in Q3 2025.
  • 101 funds tracked by Wall St. Rank held Contango Silver & Gold Inc as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.